Cargando…
Liquid Biopsy Detects Relapse Five Months Earlier than Regular Clinical Follow-Up and Guides Targeted Treatment in Breast Cancer
Genetic alterations in circulating tumor DNA (ctDNA) are an emerging biomarker for the early detection of relapse and have the potential to guide targeted treatment. ctDNA analysis is often performed by droplet digital PCR; however, next-generation sequencing (NGS) allows multigene testing without h...
Autores principales: | Cheng, Fiona Tsui-Fen, Lapke, Nina, Wu, Chin-Chu, Lu, Yen-Jung, Chen, Shu-Jen, Yu, Pei-Ning, Liu, Yen-Ting, Tan, Kien Thiam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754891/ https://www.ncbi.nlm.nih.gov/pubmed/31583146 http://dx.doi.org/10.1155/2019/6545298 |
Ejemplares similares
-
Advanced Lung Adenocarcinoma Patient with ERBB2 Amplification Identified by Comprehensive Genomic Profiling Benefits from Trastuzumab
por: Tao, Chi-Wei, et al.
Publicado: (2020) -
Genetic alterations and their therapeutic implications in epithelial ovarian cancer
por: Lapke, Nina, et al.
Publicado: (2021) -
A spectroscopic liquid biopsy for the earlier detection of multiple cancer types
por: Cameron, James M., et al.
Publicado: (2023) -
Kidney biopsy in patients with glomerulonephritis: is the earlier the better?
por: Haider, Dominik G, et al.
Publicado: (2012) -
Planning Steps Forward in Development: In Girls Earlier than in Boys
por: Unterrainer, Josef M., et al.
Publicado: (2013)